Lv7
4995 积分 2021-04-27 加入
CAR-T therapy in solid tumors
23小时前
已完结
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
14天前
已完结
A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
1个月前
已完结
IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors
1个月前
已完结
IL-12 Deaths: Explanation and a Puzzle
1个月前
已完结
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis
1个月前
已完结
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
1个月前
已关闭
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial
1个月前
已完结
A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
1个月前
已完结
Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study
2个月前
已完结
皖公网安备34019202002308
